-
CPR values as a continuous variable have independent predictive value for subsequent coronary events in apparently healthy women.
-
Data showed a strong trend toward benefit with ICD therapy in patients with nonischemic cardiomyopathy.
-
The pre-discharge initiation of beta blocker therapy for decompensated heart failure patients increased the number of patients on beta blockers at 60 days without an increase in length of stay or adverse effects.
-
-
The British government will soon allow over-the-counter sales of Mercks simvastatin (Zocor), marking the first time any country has allowed the OTC sale of a statin.
-
In selected patients, cardiac resynchronization therapy with a pacemaker or pacemaker-defibrillator improves their clinical course and the addition of a defibrillator with cardiac resynchronization therapy alone further reduces mortality.
-
Current rofecoxib use was associated with a higher risk of acute myocardial infarction or admission for heart failure compared to celecoxib.
-
The dose of aspirin after discharge for acute coronary syndromes may affect the 6-month clinical course.
-
Long-term treatment with aspirin is associated with a progressive diminution in platelet sensitivity to the drug.
-
Drs. Stuart Connolly and Stefan Hohnloser presented results from the Defibrillator In Acute Myocardial Infarction Trial (DINAMIT). Prior studies had shown that patients with recent myocardial infarction and left ventricular dysfunction are at high risk for death in the period after myocardial infarction.